Keywords: پادبَند یا ضد انعقاد; Atrial fibrillation; Acute care; Emergency department; Rate control; Rhythm control; Anticoagulation;
مقالات ISI پادبَند یا ضد انعقاد (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پادبَند یا ضد انعقاد; Anticoagulation; Atrial fibrillation; Catheter ablation; Electrical isolation; Left atrial appendage;
Keywords: پادبَند یا ضد انعقاد; Novel oral anticoagulants; Vitamin K antagonists; Atrial fibrillation ablation; Anticoagulation; Thromboembolism;
Keywords: پادبَند یا ضد انعقاد; Direct oral anticoagulants; Venous thromboembolism; Deep venous thrombosis; VTE chemoprophylaxis; VTE extended therapy; Anticoagulation; Perioperative bridging;
Keywords: پادبَند یا ضد انعقاد; Gastric bypass; Sleeve gastrectomy; Anticoagulation; Warfarin; INR; Bleeding; Thrombosis;
Keywords: پادبَند یا ضد انعقاد; Atrial fibrillation burden; Diagnosis; Clinical outcomes; Anticoagulation; AF; atrial fibrillation; AHRE; atrial high rate episode; CI; confidence interval; CIED; cardiac implantable electronic device; CRT; cardiac resynchronization therapy; ECG; electroc
Keywords: پادبَند یا ضد انعقاد; Prosthetic valve; Pregnancy; Anticoagulation; Neuraxial anaesthesia; Postpartum haemorrhage;
Keywords: پادبَند یا ضد انعقاد; anticoagulation; DOAC; nephrotic; thrombosis;
Keywords: پادبَند یا ضد انعقاد; Heart Transplantation; Mechanical Circulatory Support; Ventricular Assist Device; Perioperative Care; Anticoagulation; Bridge to Transplantation;
Keywords: پادبَند یا ضد انعقاد; Anticoagulation; arthritis; Baker's cyst; cellulitis; compartment syndrome; deep vein thrombosis; diabetic foot; lymphoedema; peripheral arterial disease; thromboembolism;
Keywords: پادبَند یا ضد انعقاد; Venous thromboembolism; Deep venous thrombosis; Pulmonary embolism; Anticoagulation; Residual thrombosis; D-Dimer;
Keywords: پادبَند یا ضد انعقاد; Atrial fibrillation; Catheter ablation; Left atrial appendage occlusion; WATCHMAN; Anticoagulation; Device-related thrombosis;
Keywords: پادبَند یا ضد انعقاد; Biventricular thrombi; Congestive heart failure; Dilated cardiomyopathy; Anticoagulation;
Keywords: پادبَند یا ضد انعقاد; Atrial fibrillation; Anticoagulation; Non-vitamin K antagonist oral anticoagulant; Warfarin; Stroke; Major bleeding;
Keywords: پادبَند یا ضد انعقاد; Left atrial appendage closure; Anticoagulation; Embolic stroke;
Keywords: پادبَند یا ضد انعقاد; Venous thromboembolism; Treatment duration; Anticoagulation; Relapses; Hemorrhages; Tromboembolia venosa; Duración del tratamiento; Anticoagulación; Recurrencias; Hemorragias;
Keywords: پادبَند یا ضد انعقاد; Retinal vein occlusion; Cardiovascular risk factors; Nonvalvular atrial fibrillation; Anticoagulation; Obstrucción venosa retiniana; Factores de riesgo vascular; Fibrilación auricular no valvular; Anticoagulación;
Keywords: پادبَند یا ضد انعقاد; Acute myocardial infarction; Cystic thrombus; Hydatid cyst; Anticoagulation;
Keywords: پادبَند یا ضد انعقاد; Ischemic stroke; cancer; hypercoagulability; NOAC; anticoagulation; prognosis;
Keywords: پادبَند یا ضد انعقاد; anticoagulation; self-management; warfarin;
Keywords: پادبَند یا ضد انعقاد; Kawasaki disease; anticoagulation; coronary artery aneurysms; AHA; American Heart Association; CAA; Coronary artery aneurysm; CT; Computed tomography; ED; Emergency department; INR; International normalization ratio; KD; Kawasaki disease; PINRR; Percentag
Keywords: پادبَند یا ضد انعقاد; Warfarin; Dosing regimen; Anticoagulation; Perioperative blood loss;
Keywords: پادبَند یا ضد انعقاد; Obstrucción venosa retiniana; Factores de riesgo vascular; Fibrilación auricular no valvular; Anticoagulación; Retinal vein occlusion; Cardiovascular risk factors; Nonvalvular atrial fibrillation; Anticoagulation;
Keywords: پادبَند یا ضد انعقاد; Tromboembolia venosa; Duración del tratamiento; Anticoagulación; Recurrencias; Hemorragias; Venous thromboembolism; Treatment duration; Anticoagulation; Relapses; Haemorrhages;
Keywords: پادبَند یا ضد انعقاد; Inferior vena cava filter; Retrievable; Anticoagulation; Trauma center; Geriatric;
Keywords: پادبَند یا ضد انعقاد; Anticoagulation; Antithrombotic; Intracranial aneurysm; Subarachnoid hemorrhage; mRS; Modified Rankin Scale; PCC; Prothrombin complex concentrate; SAH; Subarachnoid hemorrhage; SDH; Subdural hematoma; VKA; Vitamin K antagonist; WFNS; World Federation of N
Keywords: پادبَند یا ضد انعقاد; antithrombin; anticoagulation; cardiopulmonary bypass; pediatrics; ACT; activated clotting time; heparin;
Keywords: پادبَند یا ضد انعقاد; ASDH; acute subdural hematomas; AT; antithrombotic agents; CSDH; chronic subdural hematomas; INR; international normalized ratio; PR; postoperative recurrence; NOS; Newcastle-Ottawa Scale; Anticoagulation; Antiplatelet; Antithrombosis; Chronic subdural he
Keywords: پادبَند یا ضد انعقاد; Acute subdural hematoma; Anticoagulation; Warfarin; Coumadin;
Keywords: پادبَند یا ضد انعقاد; Pulmonary embolism; Right ventricular dysfunction; Risk-adapted treatment; Anticoagulation;
Keywords: پادبَند یا ضد انعقاد; Coagulation; Anticoagulation; Pregnancy; Reference intervals;
Keywords: پادبَند یا ضد انعقاد; Anticoagulation; Pharmacist; Certificate program;
Keywords: پادبَند یا ضد انعقاد; Endovascular treatment; anticoagulation; hemorrhage; ischemic stroke; safety; meta-analysis;
Keywords: پادبَند یا ضد انعقاد; Ross procedure; Pulmonary autograft; Pulmonary allograft; Aortic stenosis; Anticoagulation; Quality of life;
Keywords: پادبَند یا ضد انعقاد; extracorporeal membrane oxygenation; extracorporeal life support; transfusion; blood management; anticoagulation; hemorrhage;
Keywords: پادبَند یا ضد انعقاد; Apixaban; Anticoagulation; Catheter ablation; Atrial fibrillation; Bleeding complication;
Keywords: پادبَند یا ضد انعقاد; Atrial fibrillation; Gender; Anticoagulation; Stroke; Mortality;
Keywords: پادبَند یا ضد انعقاد; Figure of 8 suture; Atrial fibrillation ablation; Venous hemostasis; Anticoagulation;
Keywords: پادبَند یا ضد انعقاد; Warfarin; International normalised ratio; Anticoagulation; Rural; Remote; Indigenous health;
Keywords: پادبَند یا ضد انعقاد; Fibrillation atriale; Fermeture d'auricule gauche; Anticoagulation; Accident vasculaire cérébral; Ãvènements hémorragiques; Atrial fibrillation; Left atrial appendage closure; Anticoagulation; Stroke; Bleeding events;
Keywords: پادبَند یا ضد انعقاد; CRRT; CRRT dose; Critical illness; Anticoagulation; Timing of dialysis;
Keywords: پادبَند یا ضد انعقاد; Anticoagulation; Trauma; Vascular; Extremity; Amputation;
Keywords: پادبَند یا ضد انعقاد; Lung cancer; Thromboembolism; Anticoagulation; Prevention; Systematic review;
Keywords: پادبَند یا ضد انعقاد; Lateral sinus thrombosis; Sigmoid sinus thrombosis; Transverse sinus thrombosis; Mild head injury; Child; Anticoagulation;
Keywords: پادبَند یا ضد انعقاد; Atrial fibrillation; Risk scores; Anticoagulation;
Keywords: پادبَند یا ضد انعقاد; Anticoagulation; Antithrombotic therapy; Triple therapy; Atrial fibrillation; Percutaneous coronary intervention; Coronary stent; Acute coronary syndrome;
Keywords: پادبَند یا ضد انعقاد; Anticoagulation; Atrial fibrillation; Warfarin; Novel anticoagulants;
Keywords: پادبَند یا ضد انعقاد; Cerebral sinus; Sinus thrombosis; Transsinus fracture; Head trauma; Antithrombotic therapy; Anticoagulation;
Keywords: پادبَند یا ضد انعقاد; Anticoagulation; Bleeding; Low molecular weight heparin; Recurrent pregnancy loss; Threatened abortion;
Keywords: پادبَند یا ضد انعقاد; Anticoagulation; computed tomography pulmonary angiogram (CTPA); embolectomy; IVC filter; massive pulmonary embolism; pulmonary embolism; submassive pulmonary embolism; thrombolysis; venous thrombo-embolism (VTE);